tiprankstipranks
EyePoint Pharmaceuticals Inc (EYPT)
NASDAQ:EYPT
US Market
EYPT
EyePoint Pharmaceuticals
RESEARCH TOOLSreports
Want to see EYPT full AI Analyst Report?

EyePoint Pharmaceuticals (EYPT) Stock News & Sentiment

1,001 Followers
Insiders Dump Shares in Global-e, EyePoint, Immunovant, Nerdy, Argan
Premium
Weekend Updates
Insiders Dump Shares in Global-e, EyePoint, Immunovant, Nerdy, Argan
8d ago
AGX
EYPT
EyePoint Highlights DURAVYU Phase 3 Progress and Cash Runway
Premium
Company Announcements
EyePoint Highlights DURAVYU Phase 3 Progress and Cash Runway
19d ago
8K
EYPT
EyePoint Sues Ocular Therapeutix Over Alleged Defamation
Premium
Company Announcements
EyePoint Sues Ocular Therapeutix Over Alleged Defamation
1M ago
8K
EYPT
EyePoint’s COMO Phase 3 Trial Puts Long-Acting DME Strategy in Focus
Premium
Company Announcements
EyePoint’s COMO Phase 3 Trial Puts Long-Acting DME Strategy in Focus
2M ago
EYPT
EyePoint Pharmaceuticals: Strong Clinical Momentum, Favorable Risk‑Reward, and Catalyst‑Rich Path to Duravyu Approval Support Buy Rating
Premium
Ratings
EyePoint Pharmaceuticals: Strong Clinical Momentum, Favorable Risk‑Reward, and Catalyst‑Rich Path to Duravyu Approval Support Buy Rating
2M ago
EYPT
EyePoint Pharma Bets Big on DuraVu in Pivotal Push
Premium
Company Announcements
EyePoint Pharma Bets Big on DuraVu in Pivotal Push
2M ago
EYPT
EyePoint Starts Global Phase 3 Trials for DURAVYU
Premium
Company Announcements
EyePoint Starts Global Phase 3 Trials for DURAVYU
2M ago
8K
EYPT
More EYPT News >

EYPT News on the Web

Suvretta Capital Management, LLC Increases Stake in Lexeo Therapeutics Inc
GuruFocus News
Neutral
EyePoint Highlights DURAVYU Phase 3 Progress and Cash Runway
TipRanks News
Neutral
Arvinas (ARVN) Moves 6.9% Higher: Will This Strength Last?
Zacks
Bearish
EyePoint Inc at RBC Capital Markets Ophthalmology Conference (Virtual) Transcript
GuruFocus News
Neutral
EyePoint (EYPT) Sues Ocular Therapeutix (OCUL) Over False Claims
GuruFocus News
Neutral
EyePoint Sues Ocular Therapeutix Over Alleged Defamation
TipRanks News
Neutral
Top Executive Makes Bold Insider Move at EyePoint Pharmaceuticals
TipRanks News
Neutral
EyePoint’s COMO Phase 3 Trial Puts Long-Acting DME Strategy in Focus
TipRanks News
Bullish

News Score - Last 7 Days

Neutral
EYPT
Sector Average
Media Buzz
This Week1 articles
Weekly Average1.25 articles
News Sentiment
This Week50%
Sector Average70%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is EYPT’s Media Buzz Sentiment?
1 articles about EYPT were published this week. In an average week, 1.25 articles are published.
    What is EYPT’s weekly average amount of articles?
    In an average week, 1.25 articles about EYPT are published.
      What is EYPT’s News Sentiment?
      50% of articles about EYPT were positive this week, compared to its sector average of 70%.
        Healthcare Stocks that are Trending in the News
        TVTXTravere Therapeutics
        HVOOpen Orphan Plc
        PBMPsyence Biomedical
        QDELQuidelOrtho
        Showing the stocks with the most bullish news sentiment over the past week